2025 IDA Annual Conference Set to Illuminate Abu Dhabi
ABU DHABI, UAE, Aug. 11, 2025 /CNW/ -- The 2025 International Dragon Award (IDA) Annual Conference will be held with grandeur from August 9 to 12, 2025 in Abu Dhabi, the dynamic capital of the United Arab Emirates and a globally renowned "City of Oil". This landmark event is set to convene over 7,000 delegates—including financial insurance elites, senior executives of insurance companies, and industry experts and scholars from across the world—to explore emerging trends, challenges and opportunities within the insurance industry.
In 1998, IMM International officially established the International Dragon Award (IDA), intending to set a fair and objective benchmark for the global insurance industry and to uphold the values of "Paragon, Perfection, Nobility". After over two decades of industry engagement, the IDA has garnered widespread acclaim and respect across the industry, establishing itself as an internationally admired honor among financial insurance practitioners. Today, a number of financial insurance institutions have incorporated IDA into their corporate recognition frameworks. By 2025, over 181,000 financial insurance elites from more than 250 insurance institutions across 17 countries and regions have earned the IDA distinction, including 585 IDA Life Members and 16 inductees into the prestigious IDA Hall of Fame. This year also sees 17 outstanding sales teams receiving the esteemed "IDA Hundred-Elite Team" title.
As a premier, high-caliber event of vital significance to the global insurance sector, the IDA Annual Conference celebrates the achievements of its members, while empowering financial insurance practitioners worldwide with cutting-edge industry insights, marketing expertise, and leadership philosophies. Since 2000, IMM International has hosted 24 editions of the conference in major cities across the globe—including Chiang Mai, Singapore, Seoul, Sydney, Kuala Lumpur, Dubai, Melbourne, Bangkok, and multiple cities in China. Its debut in Abu Dhabi in 2025 marks a significant milestone in the conference's global journey.
Centered on the theme "Devotion", this year's conference will unite over 120 senior executives from insurance companies, excellent sales agency leaders, top-tier sales agents, and experts and scholars from various fields globally. Featuring over 60 high-value, in-depth sharing sessions—including 12 main sessions, 43 breakout sessions, and 10 "International Finance Outlook Forum" sessions convening financial experts and senior executives from insurance companies—the event will offer a dynamic, open, and interdisciplinary platform for meaningful exchange of ideas, driving continued prosperity and development across the insurance industry.
IDA Grand Celebration: Thousands Rise to Claim their IDA Honor
As the global insurance industry navigates new challenges emerging in the 2025 volatile economic climate, a resilient cohort of outstanding insurance professionals has chosen to rise against the headwinds, ultimately earning the prestigious IDA honor with their exceptional performance and unwavering resolve.
As the highest tribute to the leading force of the industry, this conference has meticulously curated two signature events: "Honor Salute" and "Dragon Night". During these ceremonial sessions, more than 4,000 IDA members will stride along the Walk of Fame marked by "Paragon, Perfection, Nobility", and step proudly onto the award stage to celebrate a glorious moment shared by dedicated achievers.
Guided by the ideals of the IDA honor, these distinguished IDA honorees have diligently fulfilled the noble mission of serving 36 households each year. With remarkable professional expertise and selfless dedication, they have not only provided robust insurance protections for their clients, but also exemplified the highest standards of excellence within the insurance industry. The "Honor Salute" and "Dragon Night" award ceremonies celebrate their individual achievements and highlight the enduring value of their professionalism and services.
Among the many accolades, two hold particular distinction:
The Worldwide Chinese Life Insurance Lifetime Achievement Award, the highest honor in the global insurance field, is bestowed upon individuals who have dedicated more than 40 years to the industry, made significant contributions, and commanded wide respect. In 2025, this prestigious accolade goes to Mr. Tan Kar Hor, who has held senior executive roles such as general manager, chief executive committee, and chairman at PAMB, CITIC-Prudential Life, AIA Group and other leading insurance companies at home and abroad. His achievements serve as a source of inspiration for insurance practitioners to embrace challenges and press forward with courage.
The IDA Hall of Fame recognizes individuals who have earned the IDA distinction for 24 consecutive years or 30 cumulative years. These exemplary honorees are crowned with a commemorative seal as a tribute to their steadfast commitment and pioneering spirit in the insurance profession.
Contributing to Industry Legacy, Forging Shared Glory:
Official Announcement of Global Rankings for IDA Member Companies
In 2024, the IDA released its Inaugural Official Announcement of Global Rankings for IDA Member Companies in Hong Kong, China, revealing key development trends and indicators of excellence within the global financial insurance industry. These insights provide invaluable guidance for financial insurance institutions and sales teams. For insurance institutions, the number of IDA members serves as a critical metric of productivity and quality. The presence of a greater number of IDA members within a financial insurance institution reflects its ability to evolve with the industry trends and maintain steady growth in overall performance & productivity, recruitment & training, and talent retention.
To further support industry advancement, the IDA Executive Committee will release the Official Announcement of 2025 Global Rankings for IDA Member Companies at the upcoming Abu Dhabi conference. Meanwhile, the IDA Data Analytics Expert Committee has been officially established, comprising distinguished insurance professionals appointed for their expertise in industry insights and trend analysis, and renowned professionalism and credibility. These experts will collaborate with the IDA Executive Committee to contribute meaningfully to the continued advancement and excellence of the financial insurance sector.
This year's official announcement also features the presentation of "IDA World Record" awards, designed to celebrate peak achievements and inspire financial insurance practitioners worldwide to benchmark against top performers, strive for continuous advancement and improvement, and ultimately create their own IDA records.
The Official Announcement of Global Rankings for IDA Member Companies embodies the mission and determination of IMM International and IDA to enhance the professional competency, image, and social standing of practitioners in the global financial insurance industry. It defines clear benchmarks for enduring excellence and sustainable growth, while offering financial insurance institutions valuable reference, guidance, and support in institutional mechanisms and product development—ultimately driving the global insurance industry's transformation toward high-quality development.
Moving forward, IDA will continue its steadfast commitment to fostering the prosperity, development, and advancement of the global financial insurance sector, partnering with leading institutions and exceptional professionals in their quest for unparalleled excellence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
33 minutes ago
- Cision Canada
AGEDB Technology Cancels Share Consolidation
VANCOUVER, BC, Aug. 11, 2025 /CNW/ - AGEDB Technology Ltd. (" AGEDB" or the " Company") (TSXV: AGET) announces that, further to the Company's news release dated June 10, 2025, the Board of Directors have determined not to proceed on the consolidation of the Company's common shares at this time. About AGEDB Technology Ltd. AGEDB Technology Ltd. (TSXV : AGET) is a leading provider of enterprise database solutions. The company specializes in advanced database technologies, including graph databases and data processing systems, offering robust solutions to clients worldwide. AGEDB Technology Ltd. On behalf of the board of directors, "Young Seung Ko" Director Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking statements." Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur. SOURCE AGEDB Technology Ltd.
Cision Canada
2 hours ago
- Cision Canada
MEDIA ADVISORY - Government of Canada to celebrate progress on National Shipbuilding Strategy at Seaspan's Vancouver Shipyards in British Columbia
GATINEAU, QC, Aug. 11, 2025 /CNW/ - The Honourable Joël Lightbound, Minister of Government Transformation, Public Works and Procurement, and Ernie Klassen, Parliamentary Secretary to the Minister of Fisheries, will participate in an event at Seaspan's Vancouver Shipyards to celebrate its progress on National Shipbuilding Strategy (NSS) projects. In addition to highlighting the significant economic benefits being generated through the NSS for Canadian shipyards and companies, this event will showcase the success of the NSS, which is growing shipbuilding expertise and creating thousands of good jobs across the country, as well as ensuring that we can build the ships the Royal Canadian Navy and Canadian Coast Guard need, right here at home. A media availability will follow. Please note that all details are subject to change. All times are local. Information for media Media wishing to attend are asked to confirm their participation by sending their name and the name of their organization to Public Services and Procurement Canada at [email protected] by Tuesday, August 12, at 7:00 am. Please include "RSVP for NSS Event" in the subject line of the email. Event location details will be shared once media are registered. Media attending are asked to arrive at 9:30 am.
Cision Canada
2 hours ago
- Cision Canada
Perimeter Announces Preliminary Unaudited Revenues for the 2025 Second Quarter; Reduces Operating Costs by ~30% as Company Focuses on Commercial Sales Pipeline and Growth Opportunities
– Webcasted Q2-2025 conference call scheduled for August 26 th at 5:00 PM EDT – TORONTO and DALLAS, Aug. 11, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced preliminary unaudited revenues for the second quarter ended June 30, 2025, senior management changes, and the creation of a Perimeter Industry Advisory Board ("IAB"). Preliminary Unaudited Second Quarter 2025 Revenues Unless otherwise indicated, all amounts in this press release are expressed in U.S. dollars. Perimeter anticipates total revenue for the second quarter of 2025 to be approximately $500,000, representing year-over-year growth of approximately 100%. Sequentially, the Company expects that greater than 35% procedure growth will result in over 50% recurring revenue growth in Q2-2025 compared to Q1-2025. This was primarily driven by stronger current Perimeter S-Series system utilization, with significantly more interoperative OTC imaging procedures performed by existing surgeon users, and at a higher price per procedure. For the six-month period ended June 30, 2025, total revenue is expected to be approximately $1.0 million, compared to $345,000 in the 6-month period ended June 30, 2024 and $846,000 for the full year ended December 31, 2024. Gross margin is expected to be approximately 69% for the second quarter and 61% for the six-month period ended June 30, 2025, respectively. "We are excited that the growing adoption, both in terms of new system placements and increased current device utilization, we saw during the first three months of the year continued through the second quarter," commented Adrian Mendes, Perimeter's Chief Executive Officer. "To put that into perspective, six-month 2025 revenue alone is estimated to surpass revenues for all of 2024. Now, as our sales pipeline continues to build, and with the Premarket Approval application for our next-generation Perimeter B-Series under review with the FDA, we anticipate a continuation of strong growth moving forward." Further, Perimeter advised that it expects initial savings from its cost control efforts will result in an approximate 30% reduction in total operating costs, starting in Q3-2025. These figures are preliminary and unaudited, and actual revenues may differ. Perimeter is providing this information due to planned investment community meetings to be held ahead of its Q2-2025 financial results release and conference call later this month. Leadership Changes Perimeter announced today the appointments of Abbey Goodman as Vice President, Sales, and Paolo DiPasquale as Vice President, Corporate Development, in a move designed to further position the Company for continued sales success and growth: Ms. Goodman brings over 20 years of medical device sales experience, most recently serving as Profound Medical's Global Chief Commercial Officer. Prior to joining Profound, she progressed through a variety of senior sales leadership roles with Hologic, Novadaq Technologies, Covidien (now Medtronic), and DePuy Mitek. Ms. Goodman earned a BS in Biological Engineering from Louisiana State University. Mr. DiPasquale brings a unique perspective as someone who has over 17 years of experience in the U.S. and Canadian capital markets across Equity Research, Institutional Equity, and Investment Banking at Canaccord Genuity and Stephens. Most recently, he served as Chief Strategy Officer of a gaming and marketing company, where he managed its successful capital raising strategy and go-public process on NASDAQ. Mr. DiPasquale is a graduate of Duquesne University with two majors: a BSc in Finance and a BSc in Investment Management. In addition, Perimeter announced that Tom Boon has recently retired as Perimeter's Chief Operating Officer. Mr. Boon will continue to help guide the Company's commercial strategy through his membership on Perimeter's newly formed IAB (please see below). "We are excited to welcome Abbey and Paolo to the Perimeter team. They bring deep expertise and leadership that will be critical as we advance our business," said Mr. Mendes. "At the same time, we want to thank Tom for his outstanding leadership and contributions to Perimeter. We look forward to continuing to work with him in his new capacity on our IAB." Creation of Perimeter Industry Advisory Board Perimeter also announces the creation of an IAB to support the Company's growth strategies across all products, channels and geographies. Chairing the IAB will be Diana Chan, Managing Director of BridgeGap Solutions Group. With over 20 years of experience in the medical device industry, Ms. Chan is a seasoned marketing leader dedicated to driving growth and innovation. She played a key role in MOLLI Surgical's journey, from building its brand presence and implementing growth strategies to its successful exit after three years of commercialization through its acquisition by Stryker Corporation. Currently, she provides advisory and mentorship in the medtech space through BridgeGap Solutions Group, a consultancy she founded to support organizations with limited resources in business and market development. Prior to MOLLI Surgical, she held executive positions at Medtronic, Bard, and Fresenius Medical Care. Ms. Chan received a BA in Administrative and Commercial Studies from Western University, and an MBA from the University of Notre Dame. The full mandate and initial composition of the IAB will be announced at a later date. Conference Call Perimeter will report its second quarter 2025 financial and operating results after market close on August 26, 2025. Following the announcement, the Company will host a conference call and live audio webcast at 5:00 pm Eastern Time to discuss the results and provide a corporate update. To participate in the call, please dial 1-800-717-1738 or 1-646-307-1865. The conference call will also be broadcast live online through a listen-only webcast, which will be posted on the Investors section of the Company's website and archived for approximately 90 days. About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSXV: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that has recently been evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month. Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the Company's results for the three and six months June 30, 2025, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding management's views regarding the second quarter, the potential benefits of Perimeter S-Series OCT and Perimeter B-Series OCT and the expected benefits of Perimeter's updated version of its ImgAssist AI are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis and Annual Information Form for the year ended December 31, 2024, which are available on Perimeter's SEDAR+ profile at and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws. Financial Outlook This press release contains a financial outlook within the meaning of applicable Canadian securities laws. The financial outlook has been prepared by management of the Company to provide an outlook for the Company's forecasted revenue for the three and six months ended June 30, 2025 and may not be appropriate for any other purpose. The financial outlook has been prepared based on a number of assumptions including the assumptions discussed under the heading "Forward-Looking Statements" herein. The actual results of the Company's operations for any period will likely vary from the amounts set forth in these projections and such variations may be material. The Company and its management believe that the financial outlook has been prepared on a reasonable basis. However, because this information is highly subjective and subject to numerous risks, including the risks discussed under the heading "Forward-Looking Statements" herein, it should not be relied on as necessarily indicative of future results. Stephen Kilmer Investor Relations Direct: 647-872-4849 Email: [email protected] Adrian Mendes Chief Executive Officer Toll-free: 888-988-7465 (PINK) Email: [email protected]
